Balyasny Asset Management
RCKT icon

Balyasny Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Balyasny Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$323K Sell
2025
Q1 		$2.35M Buy
2023
Q4 		– Sell
2023
Q3 		$701K Buy
2023
Q1 		– Sell
2022
Q4 		$10.6K Sell
2022
Q3 		$794K Buy
2017
Q1 		– Sell
2016
Q4 		$440K Buy
2016
Q3 		$474K Buy